You are here: Home » Current Affairs » Coronavirus » News
Business Standard

Poonawalla urges countries to be patient, Serum to prioritise India needs

Apart from making efforts to meet the requirements of India, the company is also trying its best to balance the needs of the rest of the world, he added

Topics
Serum Institute of India | Coronavirus Vaccine

Press Trust of India  |  New Delhi 

Adar Poonawalla, CEO of Serum Institute of India, covid, coronavirus, vaccine
Adar Poonawalla, CEO of Serum Institute of India, before the first shipment of Covishield leaves the firm’s Pune plant. Photo: twitter/Adar Poonawalla

Adar Poonawalla, CEO of vaccine major (SII), on Sunday urged other countries to be patient as they wait for the supplies of COVID-19 vaccine, Covishield, as the company has been directed to prioritise the needs of India.

Apart from making efforts to meet the requirements of India, the company is also trying its best to balance the needs of the rest of the world, he added.

"Dear countries and governments, as you await #COVISHIELD supplies, I humbly request you to please be patient, @SerumInstIndia has been directed to prioritise the huge needs of India and along with that balance the needs of the rest of the world. We are trying our best", Poonawalla said in a tweet.

On February 15, the World Health Organisation (WHO) listed two versions of the AstraZeneca/Oxford COVID-19 vaccine for emergency use, giving the green light for these vaccines to be rolled out globally through COVAX.

The vaccines are produced by AstraZeneca-SKBio (Republic of Korea) and the

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

First Published: Sun, February 21 2021. 12:09 IST
RECOMMENDED FOR YOU